Clinical trial

Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)

NCT07050472

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2025-08-11

PhaseN/A

Study timeline

Study start (actual)2025-08-11Date precision: day

Registry last updated2026-02-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small-cell Lung Cancerunresolved

Interventions

Sponsors & collaborators

Anhui Shi, MDlead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07050472 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.